⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17188776 | 0.93 | — | — | |
| SCHEMBL17188751 | 0.91 | — | — | |
| SCHEMBL17188788 | 0.90 | — | — | |
| SCHEMBL17188764 | 0.90 | — | — | |
| SCHEMBL17188712 | 0.90 | — | — | |
| SCHEMBL17188727 | 0.89 | — | — | |
| SCHEMBL17188740 | 0.89 | — | — | |
| SCHEMBL17188729 | 0.89 | — | — | |
| SCHEMBL17188716 | 0.88 | — | — | |
| SCHEMBL17188718 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2265606-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2015-10-21 | — | — | EP | disclosed |